Cargando…
Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study
BACKGROUND: Comprehensive readmission morbidity studies after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are scarce. This study aimed to investigate readmissions and in-hospital morbidity after CRS and HIPEC. METHODS: The national in-hospital patient register w...
Autores principales: | Dranichnikov, Paul, Graf, Wilhelm, Cashin, Peter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137266/ https://www.ncbi.nlm.nih.gov/pubmed/32252768 http://dx.doi.org/10.1186/s12957-020-01837-4 |
Ejemplares similares
-
Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Dranichnikov, Paul, et al.
Publicado: (2021) -
ASO Author Reflections: Changes in Coagulation Biomarkers and the Risk for Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Dranichnikov, Paul
Publicado: (2021) -
Severe pulmonary complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are common and contribute to decreased overall survival
por: Sand, Olivia, et al.
Publicado: (2021) -
Predicting Early and Late Readmissions Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Moon, Eui Whan, et al.
Publicado: (2021) -
ASO Author Reflections: Can Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy be Improved?
por: Graf, Wilhelm, et al.
Publicado: (2019)